
The PCCTC
@thepcctc
The Prostate Cancer Clinical Trials Consortium (PCCTC) translates scientific discoveries to improved standards of care.
ID: 3059750296
http://pcctc.org 24-02-2015 18:20:44
2,2K Tweet
1,1K Followers
829 Following

The PCCTC-managed Prostate Cancer Promise featured in CDMRP report on impactful #prostatecancer research to improve the lives of those affected cdmrp.health.mil/pcrp/research_…

PCCTC Investigator Rana McKay, MD, FASCO (UC San Diego Health) named #LEAD2024 Woman Oncologist of the Year. Congratulations!

Very hopeful our STEAP1 CART from Fred Hutch Cancer Center makes difference for patients with advanced CRPC! 🙏 Lee Lab Vipul Bhatia National Cancer Institute #PromiCell for science and partnership. PCF Science Tanya Dorff Neeraj Agarwal, MD, FASCO Petros Grivas @morr316 The PCCTC


Optimal imaging standards for #mCSPC. @morr316 Memorial Sloan Kettering Cancer Center joins Alicia Morgans, MD, MPH Dana-Farber explaining how conventional imaging methods like PSA tracking are insufficient for monitoring disease progression in the era of adv ARSIs > bit.ly/460naNk


Neuroendocrine prostate cancer (NEPC) is a rare and aggressive subtype of prostate cancer. Alicia Morgans, MD, MPH & Oliver Sartor discussed options for patients with NEPC during our PCF Patient & Caregiver Virtual Summit on Advanced Prostate Cancer. Watch: tinyurl.com/y9k29fvk


Register for the 3rd Annual Prostate Cancer Patient Summit hosted by UC San Diego Health Moores Cancer Center Prostate Cancer Foundation na.eventscloud.com/website/79429/ on 1/31/2025-2/1/2025 at UCSD Park and Market.


New webinar now available! The Oncology Institute recently partnered with Trial Library for an impactful webinar, “Decentralized Community-Engaged Recruitment to a Prostate Cancer Registry Study.” docs.google.com/forms/d/e/1FAI…


Case-based discussion on navigating the evolving landscape of castrate-resistant #ProstateCancer management. Oliver Sartor, MD Mayo Clinic joins Rana McKay, MD, FASCO UC San Diego as part of an independent medical education initiative on UroToday > bit.ly/3VD9cOk Bayer | Pharmaceuticals


Join us during Men’s Health Awareness month for updates in prostate cancer treatments and our lessons learned from our Community Think Tank. Open to all patients and caregivers. UC San Diego Health Moores Cancer Center UCSD Health Moores Cancer Center COE Prostate Cancer Foundation The PCCTC UC San Diego Health


Hispanic patients more likely to be diagnosed with stage IV prostate cancer. Upwards to 30%. We need to do better. UCSD Health Moores Cancer Center COE UC San Diego Health Prostate Cancer Foundation The PCCTC OncoAlert


Prostate Network invites all survivors, partners, and those helping in the fight to join us Wed December 4th 6:30 pm CST to learn about genetics from @KUCancerCenter & The PCCTC in person at Gilda's Club KC 21 West 43rd KC, MO or simultaneously in our zoom bit.ly/3hvdbpf



An original investigation from PCCTC investigator Dan George and colleagues, "Physician Reasons for or Against Treatment Intensification in Patients With Metastatic Prostate Cancer" published in JAMA Netw Open: jamanetwork.com/journals/jaman…

PCCTC investigator Evan Y. Yu, MD (UW Department of Medicine) discusses therapeutic goals of newly diagnosed metastatic hormone-sensitive prostate cancer via Targeted Oncology: targetedonc.com/view/newly-dia…



📷 The PCCTC-managed Prostate Cancer Promise Registry will add to our understanding of how genetic differences affect patient outcomes, help family members understand their own risk of cancer, and guide discovery of new personalized treatments. To learn more visit prostatecancerpromise.org
